Dr. Michael R. Zile, MD

Dr. Zile practices at MUSC University Hospital in Charleston, South Carolina.

Dr. Zile's NPI, 1760590707, was assigned on August 29, 2006. Dr. Zile graduated from Rush Medical College of Rush University in 1977. Dr. Zile holds South Carolina license 14063.

Dr. Zile's primary practice is MUSC University Hospital, at 171 Ashley Ave, Charleston, SC 29425 in Charleston County. The practice phone is (843) 792-1414.

Dr. Zile's primary practice is MUSC University Hospital in Charleston, South Carolina. Dr. Zile is also affiliated with MUSC Health University Medical Center. The medical group on file is MUSC Health. Dmand AI also links Dr. Zile to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zile practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Zile's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Zile is licensed in South Carolina.

CMS data shows 1,188 Medicare services from Dr. Zile across 8 procedure codes in 2024, for 919 Medicare patients. Medicare paid $20,943 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 919 Medicare patients who saw Dr. Zile in 2024. The largest group is 75 to 84, with 373 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zile's median patient age at 64, with 46% women.

In 2024, Dr. Zile wrote 488 Medicare Part D claims for 52 patients. 72% of them were for generic drugs. CMS names the drug for 352 of them, across 14 drugs with 11 or more claims each, at $121,562 in total drug cost. In 2023, CMS named 368 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Zile for performance year 2024, reported as part of a group. Dr. Zile accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 45 papers to Dr. Zile, published from 2023 to 2025. 2024 was the busiest year, with 30. The most frequent topics are Heart Failure, Stroke Volume and Angiotensin Receptor Antagonists. Dr. Zile has published most often in Eur J Heart Fail. Dr. Zile's most frequent co-authors are Scott David Solomon, MD, Muthiah Vaduganathan, MD, MPH and Akshay Suvas Desai, MD.

CMS Open Payments shows 595 general payments to Dr. Zile from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 88% of the total. CVRx, Inc. paid the most, $233,750. It also lists 159 research payments totaling $251,206 from 2016 to 2025, naming 1 clinical trial.

Dr. Zile graduated from Rush Medical College of Rush University in 1977.